Pursuant to Regulations 39 (3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Titan Biotech has informed regarding the issue of Duplicate Share Certificates, as per the details are enclosed.
The above information is a part of company’s filings submitted to BSE.